Syntenin-1-mediated arthritogenicity is advanced by reprogramming RA metabolic macrophages and Th1 cells.
Anja MeyerRyan E SienesWes NijimBrian ZanottiSadiq UmarMichael V VolinKatrien Van RaemdonckMyles J LewisCostantino PitzalisShiva AramiMina Al-AwqatiHuan J ChangPim JetanalinLarissa Valor-MéndezNadera SweissShiva ShahraraPublished in: Annals of the rheumatic diseases (2023)
The syntenin-1/SDC-1 pathway plays a critical role in the inflammatory and metabolic landscape of RA through glycolytic MΦ and Th1 cell cross-regulation (graphical abstract).